Back to search

Article

Sertad4 regulates pathological cardiac remodeling.

2026-03-20

Abstract excerpt

Cardiac fibrosis driven by persistent myofibroblast activation is a major contributor to adverse ventricular remodeling and heart failure. Bromodomain and extra-terminal domain (BET) inhibition reduces fibrosis and hypertrophy in preclinical models, but direct targeting of the BET co-activator BRD4 is limited by family homology and potential systemic toxicity. Sertad4 (SERTA domain containing protein 4) is a BRD4-...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
341d74c0-8f74-5b8f-b7a9-397bb6146bd6
DOI
10.64898/2026.03.18.708586
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Sertad4 regulates pathological cardiac remodeling.DOI 10.64898/2026.03.18.708586
Select a neighboring publication to make it the new centre.